The Week In... Medical Devices (09-13/12)
  • Posted on: 13/12/2019
  • Category: Industry

The Week In... Medical Devices (09-13/12)

The ABHI teams up with ITN to explore the impact of tech on healthcare services, a COPD treatment receives CE marking, an NHS hospital begins using robotics in knee surgery, and UK cancer patients now have access to a treatment allowing clinicians to see the position and size of tumours in real time.

Interested in Star’s innovative outsourcing and resourcing solutions?

Contact Operations Director, Mark Ward, on 07872 105 540 or email

On the hunt for a new role, or just curious?

Visit our candidate page, submit your CV to, or give our offices a ring!

ABHI teams up with news team to explore the impact of technology on healthcare services

The Association of British HealthTech Industries and ITN Productions Industry News have co-produced a news and current affairs-style programme, Transforming Healthcare, exploring the healthtech sector and how technology is transforming the way our health services are delivered.

Cardiovascular Medical Devices Market to show Tremendous Growth by 2025 | Medtronic, Abbott,Sorin

Latest Study on Industrial Growth of Global Cardiovascular Medical Devices Market 2019-2025.

COPD treatment system receives CE marking

The RejuvenAir System is a cryosurgical device which applies Metered Cryospray ("MCS") of liquid nitrogen at -196◦C to targeted areas within the lungs through a bronchoscopic procedure. The extreme cold flash freezes damaged surface area lung cells which induces a rejuvenative healing process.

NHS Hospital begins using robotic for knee replacement surgery

The hospital, which is one of Europe’s largest elective orthopaedic centres, anticipates that approximately 300 patients will benefit from the robotic procedure in the first year.

Genesis Care launches MRIdian radiotherapy in the UK

Patients in the UK now have access to MRIdian, a technology from GenesisCare which combines magnetic resonance imaging (MRI) with precise radiotherapy beams.


While you’re here…

…and are interested in our content, why not sign up to our newsletter? It’s just below here.